Kinetics of P-glycoprotein-mediated efflux of paclitaxel

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1236-1242

  Jang, Seong Hoon ^a   Guillaume Wientjes, M ^a   Au, Jessie L S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL STRAIN MCF 7; DRUG ACCUMULATION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ALGORITHMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; GENES, MDR; HUMANS; MODELS, BIOLOGICAL; P-GLYCOPROTEIN; PACLITAXEL; REPRODUCIBILITY OF RESULTS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034893953     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pharmacodynamics of immediate and delayed effects of paclitaxel: Role of slow apoptosis and intracellular drug retention
2. Characterization of a human myeloid leukemia cell line highly resistant to taxol
3. P-glycoprotein, multidrug resistance and tumor progression
4. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters
5. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator LY335979
6. Substoichiometric binding of taxol suppresses microtubule dynamics
7. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
8. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-π
9. Biochemistry of multidrug resistance mediated by the multidrug transporter
10. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators
11. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446
12. 2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer
13. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
14. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
15. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death
16. Paclitaxel pharmacokinetics and pharmacodynamics
17. Computational model of intracellular pharmacokinetics of paclitaxel
18. P-glycoprotein overexpression increases maximum induction of apoptosis by Taxol
19. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
20. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
21. Taxol binds to cellular microtubules
22. Taxol binds to polymerized tubulin in vitro
23. Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium
24. Cellular uptake and efflux of docetaxel (taxotere) and paclitaxel (taxol) in P388 cell line
25. Taxol: Pharmacology, metabolism and clinical implications
26. Binding of taxol to plastic and glass containers and proteins under in vitro conditions
27. Clinical pharmacokinetics of paclitaxel
28. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine
29. Taxol transport by human intestinal epithelial Caco-2 cells